Nucleic acid inhibitor

Compounds that inhibit cell production of DNA or RMA
Image illustrates DNA, RNA, and protein synthesis. The first two are nucleic acids.

A nucleic acid inhibitor is a type of antibacterial that acts by inhibiting the production of nucleic acids. There are two major classes: DNA inhibitors and RNA inhibitors.[1] The antifungal flucytosine acts in a similar manner.

DNA inhibitors

Classic DNA inhibitors such as the quinolones act upon DNA gyrase as a topoisomerase inhibitor.[2] Another group of DNA inhibitors, including nitrofurantoin and metronidazole, act upon anaerobic bacteria.[3] These act by generating metabolites that are incorporated into DNA strands, which then are more prone to breakage.[4] These drugs are selectively toxic to anaerobic organisms, but can affect human cells.[citation needed]

RNA inhibitors

RNA inhibitors such as rifampin, act upon DNA-dependent RNA polymerase.[5]

Antifolates (DNA, RNA, and protein)

Antifolates act primarily as inhibitors of both RNA and DNA, and are often grouped with nucleic acid inhibitors in textbooks. However, they also act indirectly as protein synthesis inhibitors (because tetrahydrofolate is also involved in the synthesis of amino acids serine and methionine), so they are sometimes considered as their own category, antimetabolites.[6] However, the term "antimetabolite", when used literally, can apply to many different classes of drugs.[citation needed]

References

  1. ^ "Antibiotics". Archived from the original on 2010-10-18. Retrieved 2009-10-05.
  2. ^ Gupta (2009). Clinical Ophthalmology: Contemporary Perspectives, 9/e. Elsevier India. pp. 112–. ISBN 978-81-312-1680-4. Retrieved 20 September 2010.
  3. ^ Ralph, E. D. (1978). "The bactericidal activity of nitrofurantoin and metronidazole against anaerobic bacteria". The Journal of Antimicrobial Chemotherapy. 4 (2): 177–184. doi:10.1093/jac/4.2.177. PMID 25874.
  4. ^ P. Denyer, Stephen; Hodges, Norman A.; P. Gorman, Sean (2004). Hugo and Russell's pharmaceutical microbiology. Oxford: Blackwell Science. pp. 215. ISBN 0-632-06467-6.
  5. ^ Calvori, C.; Frontali, L.; Leoni, L.; Tecce, G. (1965). "Effect of rifamycin on protein synthesis". Nature. 207 (995): 417–8. Bibcode:1965Natur.207..417C. doi:10.1038/207417a0. PMID 4957347. S2CID 4144738.
  6. ^ "BSCI 424 Pathogenic Microbiology -- Mechanisms of Antibiotic Action and Resistance".
  • v
  • t
  • e
Major chemical drug groups – based upon the Anatomical Therapeutic Chemical Classification System
gastrointestinal tract
/ metabolism (A)blood and blood
forming organs (B)cardiovascular
system (C)skin (D)genitourinary
system (G)endocrine
system (H)infections and
infestations (J, P, QI)malignant disease
(L01–L02)immune disease
(L03–L04)muscles, bones,
and joints (M)brain and
nervous system (N)respiratory
system (R)sensory organs (S)other ATC (V)
  •  Drugs
  • Pharmacological classification systems
  • ATC codes
  •  Medicine portal
  • v
  • t
  • e
Antibacterials that inhibit nucleic acid (J01E, J01M)
Antifolates
(inhibit bacterial
purine metabolism,
thereby inhibiting
DNA and RNA
synthesis)
DHFR inhibitor
Sulfonamides
(DHPS inhibitor)
Short-acting
Intermediate-acting
Long-acting
Other/ungrouped
Combinations
Other DHPS inhibitors
Quinolones
(inhibit bacterial
topoisomerase
and/or DNA gyrase,
thereby inhibiting
DNA replication)
1st generation
Fluoroquinolones
2nd generation
3rd generation
4th generation
Veterinary
Newer non-fluorinated
Related (DG)
Anaerobic DNA
inhibitors
Nitroimidazole derivatives
Nitrofuran derivatives
RNA synthesis
Rifamycins/
RNA polymerase
Lipiarmycins


Stub icon

This systemic antibiotic-related article is a stub. You can help Wikipedia by expanding it.

  • v
  • t
  • e